CYP3A variation and the evolution of salt-sensitivity variants

Area of Science:

• Genetics
• Pharmacogenomics
• Human Evolution

Background:

• Cytochrome P450 3A (CYP3A) enzymes are crucial for metabolizing drugs and environmental compounds.
• CYP3A4 and CYP3A5 genes are significant in pharmacogenetics, influencing over 50% of marketed drugs.
• Existing genetic variants do not fully explain observed drug response variability.

Purpose of the Study:

• To identify conserved coding and noncoding regions in CYP3A4 and CYP3A5 using comparative genomics.
• To investigate interpopulation differences in genetic variant frequencies and haplotype structures.
• To explore the geographic distribution of CYP3A5*1/*3 and AGT M235T polymorphisms and their correlation with environmental factors.

Main Methods:

• Comparative genomics to identify conserved regions in CYP3A4 and CYP3A5.
• Resequencing of these regions in ethnically diverse human populations.
• Genotyping of CYP3A5*1/*3 polymorphism in over 1,000 individuals from 52 global populations.
• Statistical analysis to assess correlations between allele frequencies and geographic location (distance from equator).

Main Results:

• Significant interpopulation differences in frequency spectrum and haplotype structure were observed.
• Non-African samples showed an excess of rare variants and high-frequency long-range haplotypes.
• CYP3A5*3 frequency exhibited extreme geographic variation, correlating with distance from the equator.
• The AGT M235T variant, linked to hypertension, showed a similar latitudinal distribution and frequency correlation with CYP3A5*1/*3.

Conclusions:

• Genetic diversity in CYP3A genes varies significantly across human populations.
• The geographic distribution of CYP3A5*3 and AGT M235T suggests a shared selective pressure related to environmental factors correlated with latitude.
• These findings highlight the role of natural selection in shaping genetic variants influencing salt homeostasis and drug metabolism.